Burstable Nutrition Team

Burstable Nutrition Team

Nutrition In-Focus

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.

224 articles
Extend your brand profile by curating daily news.

Articles

AI-Driven Smart Knee Sleeve Shows Promise in Preventing ACL Injuries Through Micro-Airbag Technology

AI-Driven Smart Knee Sleeve Shows Promise in Preventing ACL Injuries Through Micro-Airbag Technology

Hippos Exoskeleton has developed an AI-driven ultra-light smart knee sleeve that deploys a micro-airbag to stabilize the knee in under 50 milliseconds. Recent testing at Cleveland Clinic's BioRobotics Center demonstrated the sleeve's ability to significantly reduce forces that cause ligament rupture, with valgus rotation re...
November 25, 2025Read more
Dr. William B. Stetson Recognized as 2025 Castle Connolly Top Doctor for Eleventh Time

Dr. William B. Stetson Recognized as 2025 Castle Connolly Top Doctor for Eleventh Time

Dr. William B. Stetson has been recognized as a 2025 Castle Connolly Top Doctor, marking the eleventh time he has received this prestigious designation. Only about 7 percent of licensed physicians in the United States are selected annually as Castle Connolly Top Doctors for their specialties within their regions. This repea...
November 25, 2025Read more
Nutriband Chairman to Present at NobleCon21, Highlighting Abuse-Deterrent Transdermal Technology

Nutriband Chairman to Present at NobleCon21, Highlighting Abuse-Deterrent Transdermal Technology

Nutriband Inc. has announced that Chairman and Co-Founder Serguei Melnik will present at NobleCon21, Noble Capital Markets' annual emerging growth equity conference. The presentation is scheduled for December 3 at 9:30 a.m. Eastern Time at Florida Atlantic University's Executive Education Complex in Boca Raton, Florida. Inv...
November 24, 2025Read more
ORGANA International Expands National Reach with Walmart.com Partnership

ORGANA International Expands National Reach with Walmart.com Partnership

ORGANA International, the natural wellness brand known for its mineral-rich, bioavailable formulations, is now available on Walmart.com, giving millions of U.S. consumers convenient access to its earth-derived health products. The brand also announced that additional retail partners, including OneLavi.com, will be launching...
November 24, 2025Read more
SEGG Media Surpasses 45 Million Live-Stream Views on Sports.com Platform

SEGG Media Surpasses 45 Million Live-Stream Views on Sports.com Platform

SEGG Media Corporation has surpassed 45 million cumulative live-stream views on its Sports.com platform, demonstrating the growing appeal of live competition content in an entertainment landscape dominated by recorded programming. The company's strategy focuses on live sports, which create concentrated engagement windows an...
November 21, 2025Read more
ABVC BioPharma Receives Additional Payment in Vitargus Licensing Agreement, Highlighting Market Potential

ABVC BioPharma Receives Additional Payment in Vitargus Licensing Agreement, Highlighting Market Potential

ABVC BioPharma has received an additional $250,000 payment from ForSeeCon Eye Corporation under their existing ophthalmic medical device licensing agreement, bringing total payments received to $816,000. The licensing agreement for Vitargus, ABVC's investigational vitreous substitute, has a total potential value of up to $9...
November 21, 2025Read more
Creative Biolabs Enhances mRNA Platform with Integrated Design, Delivery, and Validation Capabilities

Creative Biolabs Enhances mRNA Platform with Integrated Design, Delivery, and Validation Capabilities

Creative Biolabs has announced a significant upgrade to its mRNA technology platform, offering an integrated end-to-end solution that spans design, delivery, and functional validation. The enhanced platform extends mRNA applications into induced pluripotent stem cell reprogramming, creating new opportunities for regenerativ...
November 21, 2025Read more
MED Holdings Acquires TotalBody.com to Expand Digital Wellness Ecosystem

MED Holdings Acquires TotalBody.com to Expand Digital Wellness Ecosystem

MED Holdings Group Inc. has announced the acquisition of TotalBody.com, a telehealth platform designed to deliver comprehensive wellness, weight loss, hormone therapy, and longevity medicine programs to patients worldwide. This strategic move represents a pivotal milestone in MED Holdings' strategy to establish a leading di...
November 19, 2025Read more
MEGASTAR Launches T35 All-in-One Strength Training System for Home Gyms

MEGASTAR Launches T35 All-in-One Strength Training System for Home Gyms

MEGASTAR has announced the T35 All-in-One Strength Training System, a comprehensive strength training solution that integrates a power cage, Smith machine, and cable crossover into a single unit. The system features true 1:1 dual pulleys and linear bearings paired with a heavy-duty structure rated to 1,800 pounds, positioni...
November 19, 2025Read more
MEGASTAR Launches W59 Multi-Function Adjustable Weight Bench for Home Gyms

MEGASTAR Launches W59 Multi-Function Adjustable Weight Bench for Home Gyms

MEGASTAR has launched the W59 Multi-Function Adjustable Weight Bench, featuring a comprehensive adjustment system and integrated training stations designed specifically for home and garage gym environments. The bench incorporates what the company calls a "12+4+3" full-adjustment system, providing 12 backrest angles ranging ...
November 19, 2025Read more
Annovis Bio Secures FDA Meeting for Parkinson's Dementia Drug Development

Annovis Bio Secures FDA Meeting for Parkinson's Dementia Drug Development

Annovis Bio Inc. has secured a Type C meeting with the U.S. Food and Drug Administration scheduled for January 2026 to discuss the clinical pathway for buntanetap in Parkinson's disease dementia. The company also reaffirmed continued progress in its Phase 3 Alzheimer's trial, which remains in full regulatory alignment on de...
November 18, 2025Read more
Inter Miami Adopts Hyperbaric Oxygen Therapy in Elite Sports Trend

Inter Miami Adopts Hyperbaric Oxygen Therapy in Elite Sports Trend

Oxygen Health Systems, a leader in ISO-certified hyperbaric oxygen chamber manufacturing, has announced the installation of a four-person hyperbaric chamber at Inter Miami Football Club, home to global icon Lionel Messi.
November 18, 2025Read more
Nutritional Products International Announces New Initiatives to Streamline U.S. Market Entry for International Brands

Nutritional Products International Announces New Initiatives to Streamline U.S. Market Entry for International Brands

With its turnkey Evolution of Distribution system, Nutritional Products International provides international health, wellness, beauty, and sports nutrition brands a fully managed entry into the world’s largest retail market — all under one roof.
November 18, 2025Read more
Annovis Bio's Buntanetap Shows Promise in Halting Cognitive Decline in Parkinson's Patients with Alzheimer's Co-pathology

Annovis Bio's Buntanetap Shows Promise in Halting Cognitive Decline in Parkinson's Patients with Alzheimer's Co-pathology

Annovis Bio Inc. released new findings from its Phase 3 early Parkinson's disease study demonstrating that buntanetap halted cognitive decline across all patients and delivered the strongest benefit in those with mild dementia and amyloid co-pathology. This subgroup represents approximately 25% of the study population and t...
November 17, 2025Read more
CNS Pharmaceuticals Reports Progress on Blood-Brain Barrier Drug Candidate for Glioblastoma

CNS Pharmaceuticals Reports Progress on Blood-Brain Barrier Drug Candidate for Glioblastoma

CNS Pharmaceuticals Inc. has reported third-quarter 2025 financial results while highlighting significant progress with its lead drug candidate TPI 287, a blood-brain barrier-permeable abeotaxane being developed for glioblastoma and other central nervous system tumors. The company's Phase 1 clinical data demonstrated potent...
November 17, 2025Read more
NRx Pharmaceuticals Reports Q3 2025 Progress in Suicidal Depression Treatments

NRx Pharmaceuticals Reports Q3 2025 Progress in Suicidal Depression Treatments

NRx Pharmaceuticals, Inc. reported third-quarter 2025 results while highlighting substantial progress across its clinical pipeline, particularly for treatments targeting suicidal depression. The company noted its first revenue-generating activities alongside key regulatory advancements for both NRX-100 and NRX-101 programs....
November 17, 2025Read more
NanoViricides Reports Progress on Broad-Spectrum Antiviral NV-387 in Quarterly Filing

NanoViricides Reports Progress on Broad-Spectrum Antiviral NV-387 in Quarterly Filing

NanoViricides, Inc. has filed its Form 10-Q for the quarter ended September 30, 2025, highlighting significant progress on its lead drug candidate NV-387, a first-in-class broad-spectrum antiviral designed to resist viral escape by mimicking conserved sulfated proteoglycan receptors used by more than 90% of viruses. The com...
November 17, 2025Read more
Molly & Me Pecans Launches Whiskey Salted Caramel Pecans, Merging Indulgence with Nutrition

Molly & Me Pecans Launches Whiskey Salted Caramel Pecans, Merging Indulgence with Nutrition

Molly & Me Pecans has unveiled its newest flavor offering, Whiskey Salted Caramel Pecans, creating a snack option that balances indulgent taste with nutritional value. The product combines the natural richness of pecans with whiskey-infused caramel and sea salt, creating what the company describes as a harmonious blend of s...
November 15, 2025Read more
Peptide Research Advances Understanding of Metabolic Regulation, Tissue Repair, and Antioxidant Mechanisms

Peptide Research Advances Understanding of Metabolic Regulation, Tissue Repair, and Antioxidant Mechanisms

Peptide research continues to advance understanding of metabolic regulation, tissue repair, and antioxidant mechanisms, with several compounds showing particular promise in experimental settings. Tirzepatide operates as a dual receptor agonist, engaging both glucose-dependent insulinotropic polypeptide and glucagon-like pep...
November 14, 2025Read more
Research Peptide Quality Control Essential for Experimental Reproducibility

Research Peptide Quality Control Essential for Experimental Reproducibility

Research peptides serve as critical molecular instruments for examining signaling pathways, receptor interactions, and various biological mechanisms in both in vitro and in vivo environments. Achieving reproducible and dependable results depends fundamentally on ensuring high purity, thorough sequence documentation, and lot...
November 14, 2025Read more
GLP-1 Medications Show 50% Lower Mortality in Colon Cancer Patients, Study Finds

GLP-1 Medications Show 50% Lower Mortality in Colon Cancer Patients, Study Finds

Recent research from UC San Diego revealed that colon cancer patients using GLP-1 medications such as Ozempic and Wegovy demonstrated a 50% lower mortality rate compared to those not taking these drugs. The findings suggest that medications already approved for specific clinical indications may have additional therapeutic b...
November 14, 2025Read more

Showing 106-126 of 224 articles (Page 6 of 11)